| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 10 Feb 25 | SNDX Syndax Pharmaceuticals | Common Stock | Sell | Dispose S | No | No | 15.504 | 13,288 | 206.02 k | 300,121 |
| 5 Feb 25 | SNDX Syndax Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 89,000 | 0.00 | 313,409 |
| 5 Feb 25 | SNDX Syndax Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 60,500 | 0.00 | 224,409 |
| 5 Feb 25 | SNDX Syndax Pharmaceuticals | Stock Options Common Stock | Grant | Acquire A | No | No | 14.65 | 364,000 | 5.33 mm | 364,000 |
| 10 Jun 24 | PYXS Pyxis Oncology | Stock Option Common Stock | Grant | Acquire A | No | No | 3.97 | 70,683 | 280.61 k | 70,683 |
| 7 Feb 24 | SNDX Syndax Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 39,000 | 0.00 | 163,909 |
| 7 Feb 24 | SNDX Syndax Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 107,250 | 0.00 | 124,909 |
| 7 Feb 24 | SNDX Syndax Pharmaceuticals | Stock Options Common Stock | Grant | Acquire A | No | No | 22.28 | 214,500 | 4.78 mm | 214,500 |
